Document Detail


Studies in myasthenia gravis. Pyridostigmine-C14 metabolism after thymectomy.
MedLine Citation:
PMID:  1237111     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pyridostigmine-carbon 14 (P-C14) excretion studies in myasthenia gravis patients who had had thymectomies failed to produce any significant difference from results observed in myasthenic patients who had not had thymectomies. Thus, change in P-C14 metabolism cannot help explain decreased anticholinesterase requirements and electromyographic changes observed in some patients following thymectomy.
Authors:
P Kornfeld; T N Mittag; G Genkins; S Horowitz; A E Papatestas
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Neurology     Volume:  25     ISSN:  0028-3878     ISO Abbreviation:  Neurology     Publication Date:  1975 Oct 
Date Detail:
Created Date:  1975-12-23     Completed Date:  1975-12-23     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0401060     Medline TA:  Neurology     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  998-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Female
Humans
Male
Middle Aged
Myasthenia Gravis / metabolism,  surgery*
Pyridostigmine Bromide / metabolism*
Thymectomy*
Chemical
Reg. No./Substance:
101-26-8/Pyridostigmine Bromide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Subacute combined degeneration of the spinal cord with cystinuria.
Next Document:  Suppression of expulsion of Aspiculuris tetraptera in hydrocortisone and methotrexate treated mice.